Positive predictive value of automated database records for diabetic ketoacidosis (DKA) in children and youth exposed to antipsychotic drugs or control medications: A tennessee medicaid study

BMC Medical Research Methodology

Volumn 11, Issue , 2011, Pages

  Bobo, William V ^a   Cooper, William O ^a   Epstein, Richard A ^a   Arbogast, Patrick G ^a,b   Mounsey, Jackie ^a   Ray, Wayne A ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; CHILD; DIABETIC KETOACIDOSIS; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; MALE; MEDICAID; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGANIZATION AND MANAGEMENT; PREDICTIVE VALUE; REPRODUCIBILITY; RETROSPECTIVE STUDY; STANDARD; STATISTICS; UNITED STATES;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CHILD; DIABETES MELLITUS, TYPE 2; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; MALE; MEDICAID; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TENNESSEE; UNITED STATES; YOUNG ADULT;

EID: 81555237207     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-11-157     Document Type: Article

References (22)

1. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside, Scotland. Medicines Monitoring Unit. Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW, Lancet 1997 350 9090 1505 1510 10.1016/S0140-6736(97)06234-X 9388398 (Pubitemid 28036554)
2. Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine. Ramaswamy K, Kozma CM, Nasrallah H, Drug Saf 2007 30 7 589 599 10.2165/00002018-200730070-00004 17604410 (Pubitemid 47037318)
3. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004). DuMouchel W, Fram D, Yang X, Mahmoud RA, Grogg AL, Engelhart L, Ramaswamy K, Ann Clin Psychiatry 2008 20 1 21 31 10.1080/10401230701844612 18297583 (Pubitemid 351302397)
4. Second-generation antipsychotic-associated diabetes mellitus and diabetic ketoacidosis: mechanisms, predictors, and screening need. Cohen D, Correll CU, J Clin Psychiatry 2009 70 5 765 766 10.4088/JCP.09ac05255 19552870
5. Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. Correll CU, Carlson HE, J Am Acad Child Adolesc Psychiatry 2006 45 771 791 10.1097/01.chi.0000220851.94392.30 16832314 (Pubitemid 43932904)
6. Population-based studies of adverse drug effects. Ray WA, N Engl J Med 2003 349 (17):1592 1594
7. Improving automated database studies. Ray WA, Epidemiology 2011 22 203 304
8. Use of Medicaid data for pharmacoepidemiology. Ray WA, Griffin MR, Am J Epidemiol 1989 129 837 849 2646920 (Pubitemid 19094261)
9. Diabetic ketoacidosis in infants, children, and adolescents: a consensus statement from the American Diabetes Association. Wolfsdorf J, Glaser N, Sperling MA, Diabetes Care 2006 29 5 1150 1159 10.2337/dc06-9909 16644656 (Pubitemid 44115263)
10. Phenomenology and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases. Jin H, Meyer JM, Jeste DV, Ann Clin Psychiatry 2002 14 1 59 64 12046641 (Pubitemid 34538833)
11. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. Newcomer JW, CNS Drugs 2005 19 uppl 1:1 93
12. Diabetic ketoacidosis and elevated serum lipase in the setting of aripiprazole therapy. Kibbey KJ, Roberts AM, Nicholson GC, Diabetes Care 2010 33 7 96 10.2337/dc10-0594 20587716
13. Diabetic ketoacidosis associated with aripiprazole. Makhzoumi ZH, McLean LP, Lee JH, Ibe AI, Pharmacotherapy 2008 28 9 1198 1202 10.1592/phco.28.9.1198 18752391
14. Diabetic ketoacidosis induced by aripiprazole in a 12-year-old boy. Dhamija R, Verma R, Diabetes Care 2008 31 6 50 10.2337/dc08-0441 18509137
15. Elevated lipase and diabetic ketoacidosis associated with aripiprazole. Reddymasu S, Bahta E, Levine S, Manas K, Slay LE, JOP 2006 7 3 303 305 16685111
16. Diabetic ketoacidosis associated with aripiprazole. Church CO, Stevens DL, Fugate SE, Diabet Med 2005 22 10 1440 1443 10.1111/j.1464-5491.2005.01628.x 16176209 (Pubitemid 41391324)
17. Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. Usher-Smith JA, Thompson MJ, Sharp SJ, Walter FM, BMJ 2011 343 4092 10.1136/bmj.d4092 21737470
18. The occurrence of diabetic ketoacidosis in non-insulin-dependent diabetes and newly diagnosed diabetic adults. Westphal SA, Am J Med 1996 101 1 19 24 10.1016/S0002-9343(96)00076-9 8686710 (Pubitemid 26285936)
19. Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome. Umpierrez GE, Murphy MB, Kitabchi AE, Diabetes Spectrum 2002 15 1 28 36 10.2337/diaspect.15.1.28
20. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences. Newton CA, Raskin P, Arch Intern Med 2004 164 (17):1925 1931
21. Ketoacidosis occurs in both type 1 and type 2 diabetes - a population-based study from Northern Sweden. Wang ZH, Kihl-Selstam E, Diab Med 2008 25 7 867 870 10.1111/j.1464-5491.2008.02461.x
22. Pediatric diabetic ketoacidosis: pathophysiology and potential for outpatient management of selected children. Bonadio WA, Pediatr Emerg Care 1992 8 5 287 290 10.1097/00006565-199210000-00010 1408982